Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
NCT ID:
NCT02856412
Eligibility Criteria:
Inclusion Criteria:
* Veterans (Male and Female) between the ages of 18-75 who are physically able to participate in an exercise program
* Meet criteria for PTSD of at least 3 months duration, OR have some symptoms of PTSD with a current CAPS score of 23 or higher, as indexed by the Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Exclusion Criteria:
* History of any psychiatric disorder with active psychosis or mania in the past 5 years
* Meet criteria for severe drug or alcohol use disorder within the past 6 months as assessed by the Structured Clinical Interview for DSM-5
* Prominent suicidal or homicidal ideation
* Currently exposed to recurrent trauma or have been exposed to a traumatic event within the past 3 months
* Pregnant
* Have a clinically significant:
* neurologic disorder
* systemic illness affecting central nervous system (CNS) function
* history of seizure disorder in the past 5 years
* and/or physical disabilities making it impossible to use exercise equipment
* Acute coronary events (i.e., Myocardial Infarction) in the past 6 months
* Moderate to severe Traumatic Brain Injury (any history of head trauma associated with the onset of persistent cognitive complaints, neurological symptoms, or loss of consciousness \> 30 minutes)
* Subjects who, in the opinion of the investigator, are otherwise unsuitable for a study of this type
* The investigators will not exclude patients with PTSD who are currently receiving individual or group therapy or patients who are currently taking antidepressant or anti-anxiety medication, but will apply the following criteria:
* patients must have been in treatment for at least 2 months
* meet symptomatic criteria for inclusion
* do not have plans to discontinue treatment during the course of the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02856412
Study Brief:
Protocol Section:
NCT02856412